Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-02 | Edgewise Therapeutics, Inc. | MOORE JOHN R
(General Counsel) |
S | Common Stock | D | 1956 | $18.91 - $18.91 | $36,987 |
| 2024-05-01 | Edgewise Therapeutics, Inc. | MOORE JOHN R
(General Counsel) |
M | Common Stock | A | 5208 | $0.00 - $0.00 | $0 |
| 2024-05-02 | Edgewise Therapeutics, Inc. | Carruthers R Michael
(Chief Financial Officer) |
S | Common Stock | D | 2157 | $18.91 - $18.91 | $40,788 |
| 2024-05-01 | Edgewise Therapeutics, Inc. | Carruthers R Michael
(Chief Financial Officer) |
M | Common Stock | A | 5208 | $0.00 - $0.00 | $0 |
| 2024-05-02 | Edgewise Therapeutics, Inc. | Derakhshan Behrad
(Chief Business Officer) |
S | Common Stock | D | 1718 | $18.91 - $18.91 | $32,487 |
| 2024-05-01 | Edgewise Therapeutics, Inc. | Derakhshan Behrad
(Chief Business Officer) |
M | Common Stock | A | 5208 | $0.00 - $0.00 | $0 |
| 2024-05-02 | Edgewise Therapeutics, Inc. | Russell Alan J
(Chief Scientific Officer) |
S | Common Stock | D | 1576 | $18.91 - $18.91 | $29,802 |
| 2024-05-01 | Edgewise Therapeutics, Inc. | Russell Alan J
(Chief Scientific Officer) |
M | Common Stock | A | 5208 | $0.00 - $0.00 | $0 |
| 2024-05-02 | Edgewise Therapeutics, Inc. | Donovan Joanne M.
(CMO) |
S | Common Stock | D | 3682 | $18.91 - $18.91 | $69,626 |
| 2024-05-01 | Edgewise Therapeutics, Inc. | Donovan Joanne M.
(CMO) |
M | Common Stock | A | 10417 | $0.00 - $0.00 | $0 |
| 2024-05-02 | Edgewise Therapeutics, Inc. | KOCH KEVIN
(President and CEO) |
S | Common Stock | D | 3152 | $18.91 - $18.91 | $59,604 |
| 2024-05-01 | Edgewise Therapeutics, Inc. | KOCH KEVIN
(President and CEO) |
M | Common Stock | A | 10417 | $0.00 - $0.00 | $0 |
| 2024-01-23 | Edgewise Therapeutics, Inc. | Carruthers R Michael
(Chief Financial Officer) |
S | Common Stock | D | 90000 | $15.78 - $15.78 | $1,419,759 |
| 2024-01-23 | Edgewise Therapeutics, Inc. | Carruthers R Michael
(Chief Financial Officer) |
M | Common Stock | A | 90000 | $1.93 - $1.93 | $173,700 |
| 2024-01-23 | Edgewise Therapeutics, Inc. | Thompson Peter A.
(Director) |
P | Common Stock | A | 454545 | $11.00 - $11.00 | $4,999,995 |
| 2024-01-23 | Edgewise Therapeutics, Inc. | OrbiMed Genesis G...
(Director) |
P | Common Stock | A | 454545 | $11.00 - $11.00 | $4,999,995 |
| 2023-12-27 | Edgewise Therapeutics, Inc. | MOORE JOHN R
(General Counsel) |
S | Common Stock | D | 8497 | $10.50 - $10.50 | $89,218 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |